MedTrace Logo

Erector Spinae Block for Thoracic Surgery

NCT05521789 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2026-02-25

No results posted yet for this study

Summary

The aim of this study is to determine if erector spinae injections with bolus infusions with local anesthetic decrease postsurgical pain and opioid consumption in patients undergoing pulmonary resection surgery.

Conditions

  • Pulmonary Neoplasm
  • Pulmonary Cancer
  • Thoracic Diseases
  • Thoracic Cancer
  • Thoracic Neoplasms

Interventions

DRUG

ESB Thoracic

Erector spinae thoracic block with bupivacaine

Sponsors & Collaborators

  • George Washington University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-22
Primary Completion
2026-12-21
Completion
2027-07-21
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05521789 on ClinicalTrials.gov